HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transient Diabetes Insipidus Following Cardiopulmonary Bypass.

Abstract
Diabetes insipidus (DI) results from inadequate output of Antidiuretic Hormone (ADH) from the pituitary gland (central DI) or the inability of the kidney tubules to respond to ADH (nephrogenic DI). ADH is an octapeptide produced in the supraoptic and paraventricular nuclei of the hypothalamus and stored in the posterior lobe of the pituitary gland. Cardiopulmonary Bypass (CPB) has been shown to cause a six-fold increased circulating ADH levels 12 hours after surgery. However, in some cases, ADH release may be transiently suppressed due to cardioplegia (cardiac standstill) or CPB leading to DI. We present the postoperative course of a 60-year-old man who developed transient DI after CPB. He was successfully treated by applying nasal desmopressin therapy. Relevant biochemical parameters should be monitored closely in patients who produce excessive urine after open heart surgery.
AuthorsMeral Ekim, Hasan Ekim, Yunus Keser Yilmaz, Ali Bolat
JournalJournal of the College of Physicians and Surgeons--Pakistan : JCPSP (J Coll Physicians Surg Pak) Vol. 25 Suppl 1 Pg. S10-1 (Apr 2015) ISSN: 1681-7168 [Electronic] Pakistan
PMID25933447 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antidiuretic Agents
  • Deamino Arginine Vasopressin
Topics
  • Antidiuretic Agents (therapeutic use)
  • Cardiopulmonary Bypass (adverse effects)
  • Coronary Artery Bypass (adverse effects)
  • Deamino Arginine Vasopressin (therapeutic use)
  • Diabetes Insipidus (diagnosis, drug therapy, etiology)
  • Humans
  • Male
  • Middle Aged
  • Polyuria (diagnosis, etiology)
  • Postoperative Complications (diagnosis, drug therapy)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: